BIOCHEETAH ANNOUNCES EXCLUSIVE LICENSING AND COMMERCIALISATION AGREEMENT WITH NIPPON KAYAKU FOR VECanDx™ IN JAPAN

BioCheetah Pte. Ltd. (Head Office: Singapore; CEO: Dr. Lee Kian Chung; hereinafter “BioCheetah”) and Nippon Kayaku Co., Ltd. (Head Office: Tokyo; President: Mr. Atsuhiro Wakumoto; hereinafter “Nippon Kayaku”) announce that the two companies have entered into an exclusive licensing and commercialization agreement to develop and market a novel urinary biomarkers-based bladder cancer diagnostic assay kit, […]

thaipr.net

15 ธ.ค. 66
1 856 857 858 859 860 3,173